bullish
Screening the Silk Road: Q2-2020 Small-Mid Cap GARP (Zulu Warrior Screening)
342 Views31 May 2020 21:10
Growth as an investment style has remained prominent over the COVID-19 period, reinforcing its decade long dominance over the value. The key...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 10-minute read)
Discussions
(Paid Plans Only)
- Screening the Silk Road: Q3 2021 High-Risk Names to Avoid17 Aug 2021
- Screening the Silk Road: Q2 2021 High Risk Names to Avoid28 May 2021
- Screening the Silk Road: Q2-2021 All Cap GARP (Zulu Warrior Screening)20 May 2021
- Notes from the Silk Road: Reality Check - Asia Pacific Valuations30 May 2020
- Notes from the Silk Road: Setting Out Our Small-Mid Cap Lemonade Stand16 Jan 2018
x